Bicarbonate

Bicarbonate

SCHEMBL7006745

CCCc1nn(C)c2c(NCc3ccc(Cl)c(Cl)c3)nc(C3CCCCC3)nc12.O=C(O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 3/20 0.37
ADORA3 P0DMS8 1/20 0.35
CDK1 P06493 1/20 0.35
CTSL P07711 1/20 0.35
SSTR3 P32745 2/20 0.35
PDE10A Q9Y233 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
GAA P10253 1/20 0.34
FFAR1 O14842 1/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
CCR2 P41597 1/20 0.34
P2RX7 Q99572 1/20 0.34
PDE3A Q14432 1/20 0.34
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL7001344 0.91 PDE5A (0.43) PDE5AF2
SCHEMBL6707582 0.91 PDE5A (0.38) PDE5ACTSLPDE10AGAAFFAR1
Bicarbonate SCHEMBL7002335 0.91 PDE5A (0.42) PDE5AHDAC1HDAC6PDE3A
SCHEMBL6709069 0.90 P2RX7 (0.33) PDE5ACDK1CTSLPDE10AGAA
SCHEMBL6709067 0.90 PDE5A (0.36) PDE5ACTSLPDE10AFFAR1HDAC1
Bicarbonate SCHEMBL7004189 0.89 P2RX3 (0.37) PDE5AHDAC1HDAC6PDE3A
Bicarbonate SCHEMBL6997209 0.89 CHRM4 (0.40) PDE5AGAA
Bicarbonate SCHEMBL6996680 0.87 SMN1; SMN2 (0.45) PDE5AGAA
SCHEMBL6706941 0.83 PDE11A (0.46) PDE5AHDAC1HDAC6
SCHEMBL6771429 0.82 PDE5A (0.46) PDE5AHDAC1HDAC6PDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355649-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GmbH (DE) 2003-10-29 EP disclosed
EP-1343506-A1 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO 4,3-D]PYRIMIDINES AND ANTITHROMBOTIC AGENTS, CALCIUM-ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GmbH (DE) 2003-09-17 EP disclosed
EP-1339410-A1 USE OF PYRAZOLO 4,3-D]PYRIMIDINES MERCK PATENT GmbH (DE) 2003-09-03 EP disclosed
EP-1210349-B1 PYRAZOLO 4,3-d]PYRIMIDINES MERCK PATENT GMBH (DE) 2003-01-29 EP disclosed
WO-2002060449-A2 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINE AND NITRATES OR THIENOPYRIMIDINES AND NITRATES MERCK PATENT GMBH (DE) 2002-08-08 WO disclosed
WO-2002049651-A1 PHARMACEUTICAL FORMULATION CONTAINING PYRAZOLO[4,3-D]PYRIMIDINES AND ANTITHROMBOTIC AGENTS, CALCIUM-ANTAGONISTS, PROSTAGLANDINS OR PROSTAGLANDIN DERIVATIVES MERCK PATENT GMBH (DE) 2002-06-27 WO disclosed
WO-2002045716-A1 USE OF PYRAZOLO[4,3-D]PYRIMIDINES MERCK PATENT GMBH (DE) 2002-06-13 WO disclosed
EP-1210349-A2 PYRAZOLO 4,3-d]PYRIMIDINES MERCK PATENT GmbH (DE) 2002-06-05 EP disclosed
WO-2001018004-A2 PYRAZOLO[4,3-d]PYRIMIDINES MERCK PATENT GMBH (DE) 2001-03-15 WO disclosed